Posted by Michael Wonder on 08 Dec 2016
Trump team said to consider Thiel associate O’Neill for FDA
8 December 2016 - In speech, said FDA could approve drugs without efficacy data.
President-elect Donald Trump’s transition team is considering a Silicon Valley investor close to billionaire Peter Thiel to head the FDA, according to people familiar with the matter.
Jim O’Neill, the Thiel associate, hasn’t been officially selected, according to the people, who asked to remain anonymous because the decision process is private, and the Trump team could still go in another direction.
O’Neill is a managing director at Thiel’s Mithril Capital Management, and last served in government during the George W. Bush administration as principal associate deputy secretary at the Department of Health and Human Services. He’s also a board member of the Seasteading Institute, a Thiel-backed venture to create new societies at sea, away from existing governments.
